Bills · HR 1750
IN COMMITTEE· 119TH CONGRESS
House BillHR 1750Health
HEARD Act of 2025
INTRO FEB 27· LAST ACTION FEB 27
READING
15MIN
COSPONSORS
5
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because rare diseases often receive less attention and funding than more common illnesses, and their impact on specific minority populations can be even less understood. If this bill becomes law, it could lead to significant new investments in research and better coordinated efforts across federal health agencies, potentially uncovering new information about why certain rare diseases disproportionately affect minority groups. This could mean earlier diagnoses, more effective treatments, and improved quality of life for patients who currently face limited options.
Without this bill, research into rare diseases affecting minority populations might continue to be fragmented and underfunded. This would mean continued disparities in health outcomes, a slower pace of discovery for new treatments, and ongoing challenges for patients and their families in getting proper care. The bill's focus on health equity aims to address historical inequalities in medical research and ensure that all populations benefit from scientific advancements.
KEY PROVISIONS
4AI-extractedPROVISION 01
Directs the NIH Director to expand, intensify, and coordinate research on rare diseases specifically impacting health equity.
This elevates research on rare diseases in minority populations as a focused priority within the NIH.
PROVISION 02
Establishes a "Coordinating Committee" composed of leaders from NIH, CDC, and FDA to align all federal activities related to rare diseases and health equity.
This ensures different agencies work together efficiently on this complex issue, rather than duplicating efforts or operating in silos.
PROVISION 03
Requires the Coordinating Committee to develop a comprehensive plan within one year for research and education activities, including studying the disproportionate impact on minority populations.
This creates a strategic roadmap for future research, ensuring a broad and targeted approach to understanding and addressing these diseases.
PROVISION 04
Mandates the NIH and specific institutes to develop a comprehensive Federal plan within 180 days, including strategies to increase diversity in genetic programs and provide clinical training.
This ensures practical steps are taken quickly to address research gaps and train healthcare professionals to better serve minority populations.
SPONSORSHIP
1 + 5
D· Washington
YRS IN OFFICE
5
BILLS LED
28
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 5 REP 0 IND 0
ACTION TIMELINE
2 EVENTSFEB 27
Introduced in House
FEB 27
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
BILL INFO
TypeHouse Bill
NumberHR 1750
Congress119th
StatusIn Committee
IntroducedFeb 27, 2025
Last actionFeb 27, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · WAYS AND MEANS COMMITTEE · INTRODUCED FEB 27, 2025
House BillHR 1750Health
HEARD Act of 2025
INTRODUCED FEB 27, 2025· LAST ACTION FEB 27, 2025
PASSAGE CHANCES
—%
READING
15 min
COSPONSORS
5
COMPLEXITY
Moderate
